US5149320.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

US5149320.Pdf ||||||||||||||||| US005 14932OA United States Patent (19) 11) Patent Number: 5,149,320 Dhaliwal et al. 45 Date of Patent: Sep. 22, 1992 (54) COMPOSITE ANESTHETIC ARTICLE AND 3,477,431 l/1969 - Walecka ................................ 604/89 METHOD OF USE 3,978,212 8/1976 Barna ....... 424/56 4,234,083 1/1980 Cohen ...... ... 604/90 (76) Inventors: Avtar S. Dhaliwal; Shabir Z. Masih, 4.599,082 7/1986 Grinnard ...... ... 604/90 both of Suite 43, 408 State of 4,630,727 12/1986 Feriani et al. ....................... 604/416 Franklin Rd., Johnson City, Tenn. 4,663,166 5/1987 Veech ................................. 424/146 37604 Primary Examiner-C. Fred Rosenbaum 21 Appl. No.: 640,096 Assistant Examiner-Sharon Finkel 22) Filed: Jan. 11, 1991 57 ABSTRACT An aqueous composition for reducing pain at the site of Related U.S. Application Data injection of local parenteral anesthetic material, for (60) Division of Ser. No. 319.343, Mar. 6, 1989, which is a improving the onset thereof, and for increasing its dura continuation-in-part of Ser. No. 179,877, Apr. 11, 1988, tion, and a means for preparing and dispensing the same, abandoned. the composition containing a local parenteral anesthetic (51) Int. Cl. ............................................ A6M 31/00 which in normal doses gives an acid pH of from about (52) U.S. Cl. ...................................................... 604/49 2.5 to about 6.9, wherein the anesthetic comprises from (58) Field of Search ...... ... 604/49, 50, 415, 89-92, about 0.5 to about 2.0% by weight of the composition, 604/82, 56, 201, 415; 424/663, 686, 43 the composition further containing sufficient NaHCO3 to maintain the pH thereof between about 7.0 and about (56) References Cited 7.6, and further containing from about 0.0004 moles of U.S. PATENT DOCUMENTS dissolved CO2 per ml of composition up to the satura 2,533,165 12/1950 Hagedorn ........................... 604/45 tion level of dissolved CO2 at a CO2 head pressure of up 2.559,23 7/195. Seemar ...... ... 604/45 to about 2.5 atmospheres. 2,764,157 9/1956 Oliva et al. ... 604/45 2,766.755 10/1956 Greene ................................ 604/45 6 Claims, 8 Drawing Sheets 100 90 80 70 60 50 40 30 20 10 0 2 4 6 8 10 12 4. 5 8 20 22 24, 26 28 30 32 34 36 TIME Minutes U.S. Patent Sep. 22, 1992 Sheet 1 of 8 5,149,320 Fig. 3 U.S. Patent Sep. 22, 1992 Sheet 2 of 8 5,149,320 ssSse S sS e Sse s C O o O O C O o Co s Od N. Vd q er n vm A H sa, a H d - dip Old J O 9 - O - U.S. Patent Sep. 22, 1992 Sheet 3 of 8 5,149,320 U.S. Patent Sep. 22, 1992 Sheet 4 of 8 5,149,320 3. 9 8 3 S. S. SR SIZE OF ACTION POTENTIAL (%) U.S. Patent Sep. 22, 1992 Sheet 6 of 8 5,149,320 e N f e L C o O A. C L du us q r r N N vm C o E (a ?c 2: A C H 2 UD U O p a U.S. Patent Sep. 22, 1992 Sheet 8 of 8 5,149,320 S s on O N Vad q r CN rv El H E is - 2 d 5, 149,320 1. 2 The data from TABLE I lead to two important con COMPOSTE ANESTHETIC ARTICLE AND clusions: METHOD OF USE (1) the parenteral solutions containing epinephrine HCl are acidic with pH of 2.74-3.1. This acidic pH is This application is a division of Ser. No. 319,343 filed 5 responsible for local tissue irritation invoking "Bee Mar. 6, 1989 which is a continuation-in-part of pending Sting-like Pain" at the site of infiltration as well as occa Ser. No. 179,877 filed Apr. 11, 1988 now abandoned. sional chemical phlebitis; and This invention concerns the modification of materials (2) the amount of uncharged lipophilic portion of the normally employed as parenteral anesthetics in acidic local anesthetic, which is essential for passive transport solution, and particularly concerns a composite article O into the neuronal axoplasm through the nerve mem and its method of use which provides in a very conve brane, in most instances, is between 0.0007%-2.44% of nient manner a buffering system for addition to these the dose. Therefore, the rate and extent of diffusion of acidic materials for reducing certain adverse physiolog the uncharged local anesthetic free base is considerably ical effects thereof such as burning or stinging generally small. This, perhaps, is responsible for the delay of resulting from injections thereof. The invention also 15 about 2-7 minutes in the onset of analgesia and a waiting concerns a unique pH buffered, neutral or slightly basic period of about 4-12 minutes before surgical procedure aqueous composition containing a normally acidic par can be started, enteral anesthetic, but wherein a pH adjustment from The advantages therefore of buffered neutral or acid to neutral or basic is made completely within a slightly basic aqueous solutions of such anesthetics are composite article in a hermetically sealed manner sub 20 substantial, however, heretofore even though there has stantially immediately prior to injection of the composi been need for a convenient and sterile means for buffer tO. ing the anesthetic solutions to the correct pH and main The acid pH ranging, for example, between 3.5 to 6.5, taining such for an appropriate period, such has not of intradermal or subcutaneous anesthetic solutions and been obvious to those conversant in the art and there of most intravenous anesthetic solutions has been impli 25 fore is not available, and little if any real use of this cated as a factor responsible for local irritation at the technology has been made. In this regard it is noted that site of injection, which leads to pain or discomfort dur the physical and chemical stability of the free base form ing the period of infiltration. The local irritation, red of such local anesthetic materials cannot be maintained ness, tenderness, pain and discomfort near the site of for more than a few hours after adjustment of pH with, injection and along the course of any proximate vein. 30 e.g., either sodium hydroxide or sodium bicarbonate, appears to be related to the nature of the substances in and therefore the commercial injections of Lidocaine, the parenteral solution and the speed of infiltration. The Mepivacaine, and Bupivacaine cannot be buffered, e.g., pH of many commonly used parenteral products such as at pH 7.4 without sacrificing the normal two or more 0.5-1.0% lidocaine HCl by itself, lidocaine HCl with years of shelf life of these materials. 1:100,000 Epinephrine, and dextrose infusion, being low 35 Principal objects therefore of the present invention (pH 3.5 to 6.5), are known to cause chemical irritation are: to provide a means and its method of use for making of tissues leading to chemical phlebitis. buffer systems such as aqueous bicarbonate solutions As background information, the free esters or amides readily available to the medical community in a conve of local anesthetics such as Lidocaine, Mepivacaine and nient and easy to use unit for the pH adjustment of Bupivacaine are basic substances due to the presence of 40 acidic parenteral anesthetic materials; to provide a the amino group. Since free base of such anesthetics are means whereby a normally acidic parenteral anesthetic only slightly soluble in water and easily form stable and material can be converted to a stable neutral or slightly water soluble salts with mineral and organic acids, the basic material practically instantly before its use and in commercial injections of Lidocaine, Mepivacaine and an extremely simple manner; and to provide novel, Bupivacaine contain their hydrochloride salts. In the 45. basic buffered parenteral anesthetic compositions hav parenteral aqueous solutions, these local anesthetics ing markedly improved analgesic onset and duration. ionize to give solutions of pH of about 4.0-6.0. In order These and other objects hereinafter appearing have to decrease the rate and extent of absorption of the local been attained in accordance with the present invention anesthetics into systemic circulation, some of the paren which is defined in one of its principal embodiments as teral solutions contain small amounts of epinephrine. SO an aqueous composition containing local parenteral This further reduces the pH of the parenteral solution to anesthetic material, which in normal doses gives an acid about 2.7-3.9. pH of from about 2.5 to about 6.9, wherein said anes Table I hereof lists the pH of various commercial thetic comprises from about 0.5 to about 2.0% by local anesthetics, along with the percent of unionized weight of the system, said composition further contain Lidocaine, Mepivacaine and Bupivacaine in the vials as 55 ing sufficient NaHCO3 to maintain the pH of said sys calculated according to equation: ten between about 7.0 and about 7.6, and also contain ing from about 0.0004 moles of dissolved CO2 per ml of pKa-pH = Log C/C. composition to a saturated amount of dissolved CO2. In another embodiment, the invention is defined as a Where: composite article useful in the buffering of normally pKa is the negative logarithm of the dissociation acidic parenteral anesthetic material for reducing the constant for the local anesthetic; adverse physiological effects thereof, said article com pH is the negative logarithm of the hydrogen ion prising a vial containing a dilute aqueous system of an concentration; acid buffer such as an alkali metal bicarbonate, and a Ci is the moles of local anesthetic in the ionized or 65 closure cap on said vial hermetically sealing said system charged form; and therein, said cap having a portion which is readily pene C is the moles of local anesthetic in the uncharged or trable by tubular needle means for withdrawing said unionized form.
Recommended publications
  • Pdf; Chi 2015 DPP Air in Cars.Pdf; Dodson 2014 DPP Dust CA.Pdf; Kasper-Sonnenberg 2014 Phth Metabolites.Pdf; EU Cosmetics Regs 2009.Pdf
    Bouge, Cathy (ECY) From: Nancy Uding <[email protected]> Sent: Friday, January 13, 2017 10:24 AM To: Steward, Kara (ECY) Cc: Erika Schreder Subject: Comments re. 2016 CSPA Rule Update - DPP Attachments: DPP 131-18-0 exposure.pdf; Chi 2015 DPP air in cars.pdf; Dodson 2014 DPP dust CA.pdf; Kasper-Sonnenberg 2014 phth metabolites.pdf; EU Cosmetics Regs 2009.pdf Please accept these comments from Toxic-Free Future concerning the exposure potential of DPP for consideration during the 2016 CSPA Rule update. Regards, Nancy Uding -- Nancy Uding Grants & Research Specialist Toxic-Free Future 206-632-1545 ext.123 http://toxicfreefuture.org 1 JES-00888; No of Pages 9 JOURNAL OF ENVIRONMENTAL SCIENCES XX (2016) XXX– XXX Available online at www.sciencedirect.com ScienceDirect www.elsevier.com/locate/jes Determination of 15 phthalate esters in air by gas-phase and particle-phase simultaneous sampling Chenchen Chi1, Meng Xia1, Chen Zhou1, Xueqing Wang1,2, Mili Weng1,3, Xueyou Shen1,4,⁎ 1. College of Environmental & Resource Sciences, Zhejiang University, Hangzhou 310058, China 2. Zhejiang National Radiation Environmental Technology Co., Ltd., Hangzhou 310011, China 3. School of Environmental and Resource Sciences, Zhejiang Agriculture and Forestry University, Hangzhou 310058, China 4. Zhejiang Provincial Key Laboratory of Organic Pollution Process and Control, Hangzhou 310058, China ARTICLE INFO ABSTRACT Article history: Based on previous research, the sampling and analysis methods for phthalate esters (PAEs) Received 24 December 2015 were improved by increasing the sampling flow of indoor air from 1 to 4 L/min, shortening the Revised 14 January 2016 sampling duration from 8 to 2 hr.
    [Show full text]
  • Ophthaine (Proparacine Hydrochloride) a Local Anaesthetic for Ophthalmic Surgery* by P
    Br J Ophthalmol: first published as 10.1136/bjo.48.2.102 on 1 February 1964. Downloaded from Brit. J. Ophthal. (1964) 48, 102, OPHTHAINE (PROPARACINE HYDROCHLORIDE) A LOCAL ANAESTHETIC FOR OPHTHALMIC SURGERY* BY P. V. RYCROFT London THERE has long been a need in ophthalmology for a pleasant, non-irritant, safe and effective local analgesic, free from such side-effects as pupil dilatation or cycloplegia. The compounds in common use to-day, such as cocaine 4 per cent. (D.D.A.), affect the pupil and desiccate the cornea, and amethocaine (Pantocain, Ponto- caine, Tetracain) and related compound amylocaine (Dorsacaine, Phenolaine) and Benzamine (Eucaine) cause stinging, irritation, blepharospasm, and conjunctival congestion. Novesine (Wander), which has a formula similar to " Ophthaine", has proved excel- lent for tonometry, but not so successful for tonography or gonioscopy, and also has the disadvantage of stinging on application. copyright. Ophthaine underwent extensive trials in the United States in the years 1950-55, and for the past 3 years has been in regular clinical use by several colleagues and myself. During this period not a single case of sensitivity has occurred, and the drug has proved to be the most satisfactory all-round analgesic available. Chemistry http://bjo.bmj.com/ Ophthaine, which takes the form of an amorphous off-white solid, is used in 0 50 per cent. concentration and is freely soluble in water and dilute acids to yield a clear solution. It is not compatible with alkalis, since the insoluble free base is liberated. The drug is prepared as a sterile solution in combination with 02 per cent.
    [Show full text]
  • A Brief History Behind the Most Used Local Anesthetics
    Tetrahedron xxx (xxxx) xxx Contents lists available at ScienceDirect Tetrahedron journal homepage: www.elsevier.com/locate/tet Tetrahedron report XXX A brief history behind the most used local anesthetics * Marco M. Bezerra, Raquel A.C. Leao,~ Leandro S.M. Miranda, Rodrigo O.M.A. de Souza Biocatalysis and Organic Synthesis Group, Chemistry Institute, Federal University of Rio de Janeiro, 21941-909, Brazil article info abstract Article history: The chemistry behind the discovery of local anesthetics is a beautiful way of understanding the devel- Received 13 April 2020 opment and improvement of medicinal/organic chemistry protocols towards the synthesis of biologically Received in revised form active molecules. Here in we present a brief history based on the chemistry development of the most 16 September 2020 used local anesthetics trying to draw a line between the first achievements obtained by the use of Accepted 18 September 2020 cocaine until the synthesis of the mepivacaine analogs nowadays. Available online xxx © 2020 Elsevier Ltd. All rights reserved. Keywords: Anesthetics Medicinal chemistry Organic synthesis Mepivacaíne Contents 1. Introduction . ............................. 00 1.1. Pain and anesthesia . ............................................... 00 1.2. Ancient techniques to achieve anesthesia . ............................... 00 1.3. The objective of this work . .......................................... 00 2. Cocaine .............................................................................................. ............................
    [Show full text]
  • Anesthetic List for MH-Susceptible Patients Anesthetic Agent Choice for the MH-Susceptible Patient
    Anesthetic List for MH-Susceptible Patients Anesthetic Agent Choice for the MH-Susceptible Patient The following anesthetic agents are known triggers of MH and are not safe for use in MH-susceptible patients: Unsafe Anesthetic Agents for MHS Patients What Drugs trigger MH and are Not Safe? Inhaled General Anesthetics Choroform (Trichloromethane, Methyltrichloride) Desflurane Enflurane Halothane Isoflurane Methoxyflurane Sevoflurane Trichloroethylene Xenon (Rarely Used) Depolarizing Muscle Relaxants Trigger MH Succinylcholine (Suxamethonium) All other anesthetic agents outside of these two categories of Volatile anesthetic agents and depolarizing muscle relaxants are considered safe (see below for a sample). Safe Anesthetic Agents for MH Patients Barbiturates / Intravenous Narcotics (Opioids) Anxiety Relieving Medications Anesthetics Alfentanil (Alfenta) Ativan (Lorazepam) Diazepam Anileridine Centrax Etomidate (Amidate) Codeine (Methyl Morphine) Dalmane (Flurazepam) Hexobarbital Diamorphine Halcion (Triazolam) Ketamine (Ketalar) Fentanyl (Sublimaze) Klonopin Methohexital (Brevital) Hydromorphone (Dilaudid) Librax Midazolam Meperidine (Demerol) Librium (Chlordiazepoxide) Pentobarbital Methadone Midazolam (Versed) Propofol (Diprivan) Morphine Paxipam (Halazepam) Thiopental (Pentothal) Naloxone Restoril (Temazepam) Oxycodone Serax (Oxazepam) Inhaled Non-Volatile General Anesthetic Phenoperidine Tranxene (Clorazepate) Nitrous Oxide Remifentanil Valium (Diazepam) Sufentanil (Sufenta Local Anesthetics Amethocaine Safe Muscle Relaxants Articaine Arduan (Pipecuronium) Bupivicaine Curare (The active ingredient is Dibucaine Tubocurraine) Etidocaine Gallamine Eucaine Metocurine Lidocaine (Xylocaine) Mivacron (Mivacurium) Levobupivacaine Neuromax (Doxacurium) Mepivicaine (Carbocaine) Nimbex (Cisatracurium) Procaine (Novocain) Norcuron (Vecuronium) Prilocaine (Citanest) Pavulon (Pancuronium) Ropivacaine Tracrium (Atracurium) Stovaine Zemuron (Rocuronium) .
    [Show full text]
  • General and Local Aesthetics
    General and Local Anesthetics Abdu Tuha (B.Pharm., MSc in Medicinal Chemistry.) Local anesthetics Local anesthetics Block the nerve that carries the pain sensation and automatic impulses in local areas of the body Prevent conduction and formation of an action potential by either full or partial blockage of sodium ion channel Used in dentistry, ophthalmology and minor surgical operations 2 7/27/2020 Local … Ester and amide type Cocaine,an alkaloid from the leaves of Erythroxylon coca, was the first local anesthetic The development of local anesthetics began after the discovery of local anesthetic properties of cocaine CH N 3 CO2CH3 O C O H Because of its addictive properties the search for non-habit 3 forming local anesthetics began 7/27/2020 CH3 N H3C H H Local … O C O H3C C O H3C O -eucaine H Tropacocaine The carbomethoxy group is not required for local action as seen in tropacocaine which lack this group The synthesis and testing of -eucaine showed a tropane ring is not a prerequisite for local anesthetic activity Based on the above findings many other simple analogs like procaine and benzocaine were synthesized H2N COOC2H5 H2N COOCH2CH2N(C2H5)2 4 Benzocaine Procaine 7/27/2020 Local … General structural features Lipophilic center Ester or Amide Bridge Hydrophilic center CH CH3 N O 3 O Aryl C X Aminoalkyl CO2CH3 NH C R2 Benzoic acid derivatives O R1 C O Anilides derivatives Cocaine H 5 7/27/2020 Local … SAR of local anesthetics The lipophilic center is usually either a cyclic or heterocyclic system The hydrophilic center
    [Show full text]
  • Comparison of 0.25% Bupivacaine with 0.375% Ropivacaine for Field Block in Inguinal Hernia Repair”
    “COMPARISON OF 0.25% BUPIVACAINE WITH 0.375% ROPIVACAINE FOR FIELD BLOCK IN INGUINAL HERNIA REPAIR” Dissertation submitted to The Tamil Nadu Dr.M.G.R. Medical University Chennai – 600032. In partial fulfilment of the regulations for the Degree of M.D.ANAESTHESIOLOGY BRANCH – X Under the guidance of Dr.R.SELVAKUMAR M.D., D.A., Professor and Head of the Department DEPARTMENT OF ANAESTHESIOLOGY K.A.P.VISWANATHAM GOVT. MEDICAL COLLEGE, TRICHY. APRIL - 2017 BONAFIDE CERTIFICATE This is to certify that this dissertation titled “COMPARISON OF 0.25 % BUPIVACAINE WITH 0.375% ROPIVACAINE FOR FIELD BLOCK IN INGUINAL HERNIA REPAIR” is a bonafide work of Dr.J.RAMYA, Post Graduate in M.D.Anaesthesiology, Department of Anaesthesiology, K.A.P.V. Government Medical College, Trichy and has been prepared by her under our guidance. This has been submitted in partial fulfilment of regulations of The Tamil Nadu Dr. M.G.R. Medical University,Chennai-32 for the award of M.D. Degree in Anaesthesiology. Prof. Dr.S.LILY MARY Dr. R.SELVAKUMAR. M.D, D.A Dean, Professor and Head of Department, K.A.P.V. Govt. Medical College, Department of Anaesthesiology Trichy. K.A.P.V. Govt. Medical College, Trichy Place:Trichy Date: DECLARATION I Dr.J.RAMYA, solemnly declare that this dissertation titled “COMPARISON OF 0.25% BUPIVACAINE WITH 0.375% ROPIVACAINEFOR FIELD BLOCK IN INGUINAL HERNIA REPAIR”, is a bonafide work done by me at K.A.P.V. Government Medical College, during 2015-2016 under the guidance and supervision of Dr.R.SELVAKUMARM.D.,D.A., Professor and Head Of the department, Department of Anaesthesiology, K.A.P.V.
    [Show full text]
  • ANESTHESIOLOGY REFLECTIONS Beta-Eucaine Bottle
    386 MAZOIT ET AL. 15. Fe´re´zou J, Gulik A, Domingo N, Milliat F, Dedieu JC, Dunel-Erb S, Chevalier 21. Park Y, Damron BD, Miles JM, Harris WS: Measurement of human chylo- C, Bach AC: Intralipid 10%: Physicochemical characterization. Nutrition 2001; micron triglyceride clearance with a labeled commercial lipid emulsion. Lipids 17:930–3 2001; 36:115–20 16. Han J, Davis SS, Washington C: Physical properties and stability of two 22. Strichartz GR, Sanchez V, Arthur GR, Chafetz R, Martin D: Fundamental emulsion formulations of propofol. Int J Pharm 2001; 215:207–20 properties of local anesthetics. II. Measured octanol:buffer partition coefficients 17. Mazoit JX, Samii K: Binding of propofol to blood components: Implica- and pKa values of clinically used drugs. Anesth Analg 1990; 71:158–70 tions for pharmacokinetics and for pharmacodynamics. Br J Clin Pharmacol 1999; 23. Denson D, Coyle D, Thompson G, Myers J: Alpha 1-acid glycoprotein and 47:35–42 albumin in human serum bupivacaine binding. Clin Pharmacol Ther 1984; 35: 18. Washington C. Stability of lipid emulsions for drug delivery. Adv Drug 409–15 Deliv Rev 1996; 20:131–45 24. Mazoit JX, Cao LS, Samii K: Binding of bupivacaine to human serum 19. Theissen O, Boileau S, Cornet C, Mazoit JX, Borrelly J, Feldman L, Laxenaire proteins, isolated albumin and isolated alpha-1-acid glycoprotein. Differences MC: Analgesia after thoracotomy by extrapleural administration of continuous bu- between the two enantiomers are partly due to cooperativity. J Pharmacol Exp pivacaine. (Article in French) Ann Fr Anesth Reanim 1993; 12:265–72 Ther 1996; 276:109–15 20.
    [Show full text]
  • Synthesis and Biological Activities of Local Anesthetics Cite This: RSC Adv.,2019,9, 41173 Shiyang Zhou,A Gangliang Huang *B and Guangying Chen*A
    RSC Advances View Article Online REVIEW View Journal | View Issue Synthesis and biological activities of local anesthetics Cite this: RSC Adv.,2019,9, 41173 Shiyang Zhou,a Gangliang Huang *b and Guangying Chen*a Local anesthetics are mainly used in stomatology, ophthalmology, gynecology and surgery to temporarily relieve pain. Local anesthetics act on nerve endings or around nerve trunks, and are combined with specific sodium ion (Na+) channel sites on the nerve membrane. They can affect the membrane potential by reducing Na+ passage through sodium ion channels, thus blocking the generation and conduction of Received 8th November 2019 nerve impulses, reversibly blocking the generation and conduction of sensory nerve impulses. Local Accepted 27th November 2019 anesthetics are used for convenience in local surgical operations and treatments. Herein, we mainly DOI: 10.1039/c9ra09287k review the research progress on local anesthetics and discuss the important aspects of design, synthesis rsc.li/rsc-advances and biological activity of various new compounds. – Creative Commons Attribution-NonCommercial 3.0 Unported Licence. 1. Introduction which is mainly used before surgery.8 11 In contrast, local anesthetics act on nerve endings or around nerve trunks, Anesthetics are a type of drug that act on the nervous system, reversibly blocking the generation and conduction of sensory causing it to be inhibited and resulting in the loss of the sense nerve impulses, and temporarily eliminating local sensation of pain.1–4 According to the different scopes of action of drugs, (mainly pain sensation) under the condition of consciousness. the department of anesthetics is divided into general anes- Moreover, it is convenient for local surgical operations and – thetics and local anesthetics.5–7 General anesthetics act on the treatments.12 14 Local anesthetics are mainly used in stomatol- central nervous system, causing it to be reversibly inhibited, ogy, ophthalmology, gynecology and surgery to relieve pain thereby resulting in a loss of consciousness and sensation.
    [Show full text]
  • Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists
    Florencio Zaragoza Dorwald¨ Lead Optimization for Medicinal Chemists Related Titles Smith, D. A., Allerton, C., Kalgutkar, A. S., Curry, S. H., Whelpton, R. van de Waterbeemd, H., Walker, D. K. Drug Disposition and Pharmacokinetics and Metabolism Pharmacokinetics in Drug Design From Principles to Applications 2012 2011 ISBN: 978-3-527-32954-0 ISBN: 978-0-470-68446-7 Gad, S. C. (ed.) Rankovic, Z., Morphy, R. Development of Therapeutic Lead Generation Approaches Agents Handbook in Drug Discovery 2012 2010 ISBN: 978-0-471-21385-7 ISBN: 978-0-470-25761-6 Tsaioun, K., Kates, S. A. (eds.) Han, C., Davis, C. B., Wang, B. (eds.) ADMET for Medicinal Chemists Evaluation of Drug Candidates A Practical Guide for Preclinical Development 2011 Pharmacokinetics, Metabolism, ISBN: 978-0-470-48407-4 Pharmaceutics, and Toxicology 2010 ISBN: 978-0-470-04491-9 Sotriffer, C. (ed.) Virtual Screening Principles, Challenges, and Practical Faller, B., Urban, L. (eds.) Guidelines Hit and Lead Profiling 2011 Identification and Optimization ISBN: 978-3-527-32636-5 of Drug-like Molecules 2009 ISBN: 978-3-527-32331-9 Florencio Zaragoza Dorwald¨ Lead Optimization for Medicinal Chemists Pharmacokinetic Properties of Functional Groups and Organic Compounds The Author All books published by Wiley-VCH are carefully produced. Nevertheless, authors, Dr. Florencio Zaragoza D¨orwald editors, and publisher do not warrant the Lonza AG information contained in these books, Rottenstrasse 6 including this book, to be free of errors. 3930 Visp Readers are advised to keep in mind that Switzerland statements, data, illustrations, procedural details or other items may inadvertently be Cover illustration: inaccurate.
    [Show full text]
  • Synthesis and Biological Activities of Local Anesthetics Cite This: RSC Adv.,2019,9, 41173 Shiyang Zhou,A Gangliang Huang *B and Guangying Chen*A
    RSC Advances View Article Online REVIEW View Journal | View Issue Synthesis and biological activities of local anesthetics Cite this: RSC Adv.,2019,9, 41173 Shiyang Zhou,a Gangliang Huang *b and Guangying Chen*a Local anesthetics are mainly used in stomatology, ophthalmology, gynecology and surgery to temporarily relieve pain. Local anesthetics act on nerve endings or around nerve trunks, and are combined with specific sodium ion (Na+) channel sites on the nerve membrane. They can affect the membrane potential by reducing Na+ passage through sodium ion channels, thus blocking the generation and conduction of Received 8th November 2019 nerve impulses, reversibly blocking the generation and conduction of sensory nerve impulses. Local Accepted 27th November 2019 anesthetics are used for convenience in local surgical operations and treatments. Herein, we mainly DOI: 10.1039/c9ra09287k review the research progress on local anesthetics and discuss the important aspects of design, synthesis rsc.li/rsc-advances and biological activity of various new compounds. – Creative Commons Attribution-NonCommercial 3.0 Unported Licence. 1. Introduction which is mainly used before surgery.8 11 In contrast, local anesthetics act on nerve endings or around nerve trunks, Anesthetics are a type of drug that act on the nervous system, reversibly blocking the generation and conduction of sensory causing it to be inhibited and resulting in the loss of the sense nerve impulses, and temporarily eliminating local sensation of pain.1–4 According to the different scopes of action of drugs, (mainly pain sensation) under the condition of consciousness. the department of anesthetics is divided into general anes- Moreover, it is convenient for local surgical operations and – thetics and local anesthetics.5–7 General anesthetics act on the treatments.12 14 Local anesthetics are mainly used in stomatol- central nervous system, causing it to be reversibly inhibited, ogy, ophthalmology, gynecology and surgery to relieve pain thereby resulting in a loss of consciousness and sensation.
    [Show full text]
  • Download [ PDF ]
    Jemds.com Original Research Article LAPAROSCOPIC CHOLECYSTECTOMY UNDER SPINAL ANAESTHESIA: STUDY IN 100 CASES Niranjan Kumar Verma1 1Professor & HOD, Department of Anaesthesiology, Jawaharlal Nehru Medical College & Hospital, Bhagalpur. ABSTRACT BACKGROUND Laparoscopic cholecystectomies are generally performed under general anaesthesia. Trials for spinal anaesthesia were not satisfactory. My experience on 100 cases with a modified technique provided very good results, where Bupivacaine and Clonidine were administered by subarachnoid route combined with peritoneal insufflation and local infiltration of Ropivacaine. METHOD One hundred ASI grade 1 and grade 2 patients undergoing elective laparoscopic cholecystectomy opting for spinal anaesthesia were given 1 mL (150 mcg) of clonidine in L1-L2 interspace followed by 3 mL (15 mg) of 0.5% heavy bupivacaine in the same interspace by separate syringes, 15 degrees head down tilt, intra-peritoneal insufflation of 0.5% Ropivacaine just after pneumoperitoneum and cannula insertion and lastly local infiltration of 0.5% Ropivacaine 2 mL at each incision at the time of skin closure. Preemptive 10-15 mg of Mephentermine IM was given to each patient. Recordings of vital parameters, pain experienced by patients, especially excruciating shoulder pain, any difficulty experienced by surgeons, need for analgesia, level of consciousness, respiratory depression, hypotension, bradycardia, pruritus were recorded at frequent intervals during operation and later in the ICU for prompt managements. RESULTS None of
    [Show full text]
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
    Molecules 2016, 21, 75; doi:10.3390/molecules21010075 S1 of S110 Supplementary Materials: Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs Fei Mao 1, Wei Ni 1, Xiang Xu 1, Hui Wang 1, Jing Wang 1, Min Ji 1 and Jian Li * Table S1. Common names, indications, CAS Registry Numbers and molecular formulas of 6891 approved drugs. Common Name Indication CAS Number Oral Molecular Formula Abacavir Antiviral 136470-78-5 Y C14H18N6O Abafungin Antifungal 129639-79-8 C21H22N4OS Abamectin Component B1a Anthelminithic 65195-55-3 C48H72O14 Abamectin Component B1b Anthelminithic 65195-56-4 C47H70O14 Abanoquil Adrenergic 90402-40-7 C22H25N3O4 Abaperidone Antipsychotic 183849-43-6 C25H25FN2O5 Abecarnil Anxiolytic 111841-85-1 Y C24H24N2O4 Abiraterone Antineoplastic 154229-19-3 Y C24H31NO Abitesartan Antihypertensive 137882-98-5 C26H31N5O3 Ablukast Bronchodilator 96566-25-5 C28H34O8 Abunidazole Antifungal 91017-58-2 C15H19N3O4 Acadesine Cardiotonic 2627-69-2 Y C9H14N4O5 Acamprosate Alcohol Deterrant 77337-76-9 Y C5H11NO4S Acaprazine Nootropic 55485-20-6 Y C15H21Cl2N3O Acarbose Antidiabetic 56180-94-0 Y C25H43NO18 Acebrochol Steroid 514-50-1 C29H48Br2O2 Acebutolol Antihypertensive 37517-30-9 Y C18H28N2O4 Acecainide Antiarrhythmic 32795-44-1 Y C15H23N3O2 Acecarbromal Sedative 77-66-7 Y C9H15BrN2O3 Aceclidine Cholinergic 827-61-2 C9H15NO2 Aceclofenac Antiinflammatory 89796-99-6 Y C16H13Cl2NO4 Acedapsone Antibiotic 77-46-3 C16H16N2O4S Acediasulfone Sodium Antibiotic 80-03-5 C14H14N2O4S Acedoben Nootropic 556-08-1 C9H9NO3 Acefluranol Steroid
    [Show full text]